BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20488215)

  • 1. Comparison of potential risks of lactic acidosis induction by biguanides in rats.
    Bando K; Ochiai S; Kunimatsu T; Deguchi J; Kimura J; Funabashi H; Seki T
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):155-60. PubMed ID: 20488215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.
    Dykens JA; Jamieson J; Marroquin L; Nadanaciva S; Billis PA; Will Y
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):203-10. PubMed ID: 18817800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grapefruit juice improves glycemic control but exacerbates metformin-induced lactic acidosis in non-diabetic rats.
    Owira PM; Ojewole JA
    Methods Find Exp Clin Pharmacol; 2009 Nov; 31(9):563-70. PubMed ID: 20094639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis therapy for lactic acidosis caused by metformin intoxication: presentation of two cases.
    Soyoral YU; Begenik H; Emre H; Aytemiz E; Ozturk M; Erkoc R
    Hum Exp Toxicol; 2011 Dec; 30(12):1995-7. PubMed ID: 21441284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of biguanides by human organic cation transporter OCT2.
    Sogame Y; Kitamura A; Yabuki M; Komuro S; Takano M
    Biomed Pharmacother; 2013 Jun; 67(5):425-30. PubMed ID: 23582785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the biguanide class of oral hypoglycemic agents on mouse embryogenesis.
    Denno KM; Sadler TW
    Teratology; 1994 Apr; 49(4):260-6. PubMed ID: 8073364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin.
    Wang DS; Kusuhara H; Kato Y; Jonker JW; Schinkel AH; Sugiyama Y
    Mol Pharmacol; 2003 Apr; 63(4):844-8. PubMed ID: 12644585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hyperlactatemic effect of biguanides: a comparison between phenformin and metformin during a 6-month treatment.
    Cavallo-Perin P; Aluffi E; Estivi P; Bruno A; Carta Q; Pagano G; Lenti G
    Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):45-9. PubMed ID: 2798990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of biguanides on the intermediate metabolism of glucose in normal and portal-strictured rats.
    Schlienger JL; Frick A; Marbach J; Freund H; Imler M
    Diabete Metab; 1979 Mar; 5(1):5-9. PubMed ID: 446834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biguanide related lactic acidosis: incidence and risk factors.
    Aguilar C; Reza A; García JE; Rull JA
    Arch Med Res; 1992; 23(1):19-24. PubMed ID: 1308787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lactic acidosis induced by phenformin: a still forgotten iatrogenic complication].
    Vecchiarelli P; Ricci F; Tessero D; Quadrani G; Natalini L
    Minerva Anestesiol; 1995 Oct; 61(10):415-20. PubMed ID: 9019672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biguanide-induced lactic acidosis.
    Chandalia HB; Rangnath M
    J Assoc Physicians India; 1990 Sep; 38(9):620-2. PubMed ID: 2266074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do risk factors for lactic acidosis influence dosing of metformin?
    Millican S; Cottrell N; Green B
    J Clin Pharm Ther; 2004 Oct; 29(5):449-54. PubMed ID: 15482389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactic acidosis in metformin therapy.
    Lalau JD; Race JM
    Drugs; 1999; 58 Suppl 1():55-60; discussion 75-82. PubMed ID: 10576527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of plasma creatinine and lactic acid in type 2 diabetic patients without renal dysfunction.
    Liu F; Lu JX; Tang JL; Li L; Lu HJ; Hou XH; Jia WP; Xiang KS
    Chin Med J (Engl); 2009 Nov; 122(21):2547-53. PubMed ID: 19951568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment.
    Bruijstens LA; van Luin M; Buscher-Jungerhans PM; Bosch FH
    Neth J Med; 2008 May; 66(5):185-90. PubMed ID: 18490795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver uptake of biguanides in rats.
    Sogame Y; Kitamura A; Yabuki M; Komuro S
    Biomed Pharmacother; 2011 Sep; 65(6):451-5. PubMed ID: 21880461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of lactate acidosis as a side effect of biguanide therapy].
    Förster H
    Fortschr Med; 1976 Dec; 94(35-36):2065-71. PubMed ID: 1010516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenformin-induced lactic acidosis: an almost forgotten complication of treatment with biguanides.
    Ko GT; Chan JC; Chow CC; Yeung VT; Li YK; Cockram CS
    Br J Hosp Med; 1995 Nov 1-14; 54(9):469-70. PubMed ID: 8564185
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lactic acidosis, hyperamylasemia, and phenformin].
    Greco AV; Ghirlanda G; Bianco A
    Minerva Med; 1992 Dec; 83(12):777-83. PubMed ID: 1283446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.